Last $20.43 USD
Change Today -0.61 / -2.90%
Volume 3.1M
As of 8:10 PM 06/19/13 All times are local (Market data is delayed by at least 15 minutes).

hologic inc (HOLX) Snapshot

Open
$20.95
Previous Close
$21.04
Day High
$21.10
Day Low
$20.41
52 Week High
01/31/13 - $23.96
52 Week Low
06/26/12 - $17.13
Market Cap
5.5B
Average Volume 10 Days
3.1M
EPS TTM
$0.17
Shares Outstanding
269.3M
EX-Date
--
P/E TM
119.2x
Dividend
--
Dividend Yield
--
Current Stock Chart for HOLOGIC INC (HOLX)

Related News

No related news articles were found.

hologic inc (HOLX) Related Businessweek News

No Related Businessweek News Found

hologic inc (HOLX) Details

Hologic, Inc. develops, manufactures, and supplies diagnostics, medical imaging systems, and surgical products for women. The company’s Breast Health segment offers full field digital mammography, C-View, screen-film mammography, computer aided detection, Trident specimen radiography, and stereotactic breast biopsy systems; healthcome mammography, breast biopsy, and breast brachytherapy products; and breast tomosynthesis, Selenia full field digital mammography platform, SecurView workstation, MammoPad breast cushions, photoconductor coatings, and Sentinelle medical MRI breast coils and workstations. Its Diagnostics segment provides APTIMA family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assays, instrumentation, Invader chemistry platform, Cervista HPV tests, and ThinPrep system. The company’s GYN Surgical segment offers NovaSure system to treat women with excessive menstrual bleeding; MyoSure system for the hysteroscopic removal of fibroids; Towerfree Hysteroscopy System for the visualization and inspection of the uterine cavity; Aquilex Fluid Control System to measure the inflow and outflow of fluid from the patient during hysteroscopic procedures; and Adiana system, a procedure for permanent female contraception. Its Skeletal Health segment provides QDR X-Ray bone densitometers that assess the bone density of fracture sites; Sahara clinical bone sonometers, which assess the bone density of heels; and Mini C-Arm imaging systems to perform minimally invasive surgical procedures on a patient’s extremities. The company sells its products through direct sales and service forces, a network of independent distributors, and sales representatives primarily in the United States, Europe, and the Asia-Pacific. The company has a strategic alliance with Quest Diagnostics Incorporated. Hologic, Inc. was founded in 1985 and is headquartered in Bedford, Massachusetts.

6,157 Employees
Last Reported Date: 11/28/12
Founded in 1985

hologic inc (HOLX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $899.7K
Chief Financial Officer, Executive Vice Presi...
Total Annual Compensation: $574.8K
Senior Vice President and General Manager of ...
Total Annual Compensation: $434.8K
Chief Administrative Officer, Senior Vice Pre...
Total Annual Compensation: $405.5K
Senior Vice President and General Manager of ...
Total Annual Compensation: $379.0K
Compensation as of Fiscal Year 2012.

hologic inc (HOLX) Key Developments

Quest Diagnostics and Hologic Form Strategic Alliance to Improve Women's Health

Quest Diagnostics Inc. and Hologic Inc. announced that they have entered into a strategic alliance to more broadly offer testing based on Hologic's APTIMA family of products, as well as to co-develop and promote advanced diagnostic solutions to improve women's health. Under a non-exclusive agreement with an initial term of five years, the companies will focus primarily on clinical areas critical to the health of women. Quest Diagnostics will transition to a broader offering of services based on Hologic's APTIMA family of products, which includes FDA-approved or cleared assays for HPV, HPV genotyping, chlamydia, gonorrhea and trichomonas vaginalis. In addition, Quest Diagnostics will continue to utilize Hologic's leading line of ThinPrep liquid-based cytology products. Quest Diagnostics will also continue to offer Hologic's APTIMA HPV mRNA-based assay nationally. Unlike other FDA-approved, DNA-based HPV tests, the APTIMA HPV assay detects messenger RNA over-expressed from two viral oncogenes that are integral to the development of cervical cancer. Hologic's APTIMA HPV assay detects E6/E7 viral mRNA from 14 high-risk types of human papillomavirus in cervical specimens. The companies will also explore opportunities to develop and expand access to new diagnostic solutions for women's health. In addition, they will implement joint programs to advance women's health issues with medical associations and patient advocacy groups and to sponsor research.

Hologic Receives FDA Approval for a New Low-dose 3D Mammography (Breast Tomosynthesis) Solution for Breast Cancer Screening

Hologic Inc. announced that the U.S. Food and Drug Administration (FDA) approved the use of Hologic's new C-View 2D imaging software. C-View 2D images may now be used in place of the conventional 2D exposure previously required as part of a Hologic 3D mammography (breast tomosynthesis) screening exam. Approval of C-View software is an important evolution in Hologic's 3D mammography screening program. Eliminating the need for additional 2D exposures will provide a better experience for patients.

Hologic Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-12-2013 11:20 AM

Hologic Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-12-2013 11:20 AM. Venue: Terranea Resort, Rancho Palos Verdes, California, United States. Speakers: Robert A. Cascella, Chief Executive Officer, President and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HOLX:US $20.43 USD -0.61

HOLX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioMerieux €74.74 EUR -1.19
MEDNAX Inc $90.42 USD -1.85
Mettler-Toledo International Inc $213.28 USD -3.44
PerkinElmer Inc $33.66 USD -0.75
Cooper Cos Inc/The $120.75 USD -0.94
View Industry Companies
 

Industry Analysis

HOLX

Industry Average

Valuation HOLX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.5x
Price/Book 1.9x
Price/Cash Flow 22.0x
TEV/Sales NM Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HOLOGIC INC, please visit www.hologic.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.